Msn Life Sciences Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DESVENLAFAXINE SUCCINATE MONOHYDRATE USP (FORM-1), with a corresponding US DMF Number 30437.
Remarkably, this DMF maintains an Active status since its submission on March 31, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 04, 2022, and payment made on January 06, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II